Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz
Clinical trial NCT06240455 · SUSPENDED
Trial details
- NCT number
- NCT06240455
- Sponsor
- Worg Biotherapeutics Inc.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2029-03-31
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.